Table 1 Comparison of clinical variables between anthracycline and control groups
Variable | Anthracycline (n = 18) | Control (n = 17) | p value |
|---|---|---|---|
Age (years) | 57.6 ± 14.6 | 48.1 ± 12.2 | 0.047 |
Male (n, %) | 14 (77) | 8 (47) | 0.601 |
Height (cm) | 168.2 ± 10.2 | 164.1 ± 8.5 | 0.206 |
Weight (kg) | 76.1 ± 15.3 | 69.7 ± 10.0 | 0.160 |
BMI (kg/m2) | 26.8 ± 4.3 | 25.9 ± 2.9 | 0.469 |
BSA (m2) | 1.86 ± 0.22 | 1.76 ± 0.15 | 0.157 |
Heart rate (bpm) | 68.7 ± 14.3 | 66.2 ± 14.8 | 0.610 |
Blood hematocrit (%) | 44.6 ± 3.7 | 44.2 ± 3.6 | 0.802 |
SBP (mmHg) | 117.2 ± 13.4 | 120.5 ± 7.5 | 0.367 |
DBP (mmHg) | 74.1 ± 8.4 | 76.9 ± 5.8 | 0.255 |
Smoking (n, %) | 1 (5) | 0 (0) | 1.000 |
Hypertension (n, %) | 5 (27) | 4 (23) | 1.000 |
Diabetes (n, %) | 2 (11) | 1 (5) | 1.000 |
Dyslipidemia (n, %) | 1 (5) | 0 (0) | 1.000 |
Framingham risk score (%) | 7.8 ± 7.0 | 3.8 ± 6.6 | 0.099 |